Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial
Authors:
- Priyanga RanasinghePRPriyanga Ranasinghe
- Priyadarshani GalappaththyPGPriyadarshani Galappaththy
- Godwin Roger ConstantineGCGodwin Roger Constantine
- Ranil JayawardenaRJRanil Jayawardena
- Hasitha Dhananjaya WeeratungaHWHasitha Dhananjaya Weeratunga
- Sirimal PremakumaraSPSirimal Premakumara
- Prasad KatulandaPKPrasad Katulanda
Open Access
- 29 September 2017
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 18 (1) , 1-8
Abstract
Previous studies have explored the anti-diabetic effects of Cinnamomum cassia extract in vivo and in vitro. However, there are no studies at present exploring the effects of the indigenous species of Sri Lankan cinnamon (Cinnamomum zeylanicum) in patients with diabetes mellitus. The present study aims to evaluate the potential effects of Cinnamomum zeylanicum extract as a pharmaceutical agent in patients with type-2 diabetes mellitus. The study will be conducted as a randomized, double-blind, placebo-controlled clinical trial for a period of 4 months at the Medical Clinic, University Medical Unit, National Hospital of Sri Lanka. A total of 210 subjects with diabetes, in three equal groups, will be recruited for the study. The patients will be randomized in a 1:1:1 ratio according to the method of block randomization and the subjects will be randomly and equally assigned into two test groups (n = 70 each) and one placebo group (n = 70). The population will be stratified at randomization based on age, gender and disease severity. The treatment drug is a capsule containing Cinnamomum zeylanicum extract as the active ingredient and the placebo capsule will contain lactose monohydrate. Two doses of Cinnamomum zeylanicum extracts (250 mg and 500 mg of the cinnamon extract) will be used. The study drugs will be double blinded to both investigators and participants. The visits and the evaluations will be done as follows: screening (visit 0), 1 month (visit 1), 2 months (visit 2), 3 months (visit 3) and 4 months (visit 4). The following primary outcome measures will be evaluated: glycosylated hemoglobin (HbA1c), fasting plasma glucose (FPG) and serum insulin. Secondary outcome measures include: Body Mass Index (BMI) and other anthropometric parameters, blood pressure, total cholesterol, low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL) and triglycerides (TAG). Data will be analyzed using SPSS version 14. We describe the protocol for a clinical trial design evaluating the effects of Cinnamomum zeylanicum (Ceylon cinnamon) in patients with type-2 diabetes mellitus. The result of the present study, positive or negative, should provide a step change in the evidence guiding current and future policies regarding the use of cinnamon dietary supplementation in patients with diabetes. Sri Lanka Clinical Trials Registry (SLCTR), identifier: SLCTR/2017/010 ( http://slctr.lk/trials/714 ). Registered on 5 April 2017; study protocol version 3.1 21 March 2017.Keywords
Funding Information
- University of Colombo (AP/03/2012/CG/08)
This publication has 29 references indexed in Scilit:
- Development of a food frequency questionnaire for Sri Lankan adultsNutrition Journal, 2012
- Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complicationsThe Review of Diabetic Studies, 2012
- Effects of Cinnamomum zeylanicum (Ceylon cinnamon) on blood glucose and lipids in a diabetic and healthy rat modelPharmacognosy Research, 2012
- Functional herbal food ingredients used in type 2 diabetes mellitusPharmacognosy Reviews, 2012
- Effectiveness of Cinnamon for Lowering Hemoglobin A1C in Patients with Type 2 Diabetes: A Randomized, Controlled TrialThe Journal of the American Board of Family Medicine, 2009
- Prevalence and projections of diabetes and pre‐diabetes in adults in Sri Lanka—Sri Lanka Diabetes, Cardiovascular Study (SLDCS)Diabetic Medicine, 2008
- Quantification of Free Coumarin and Its Liberation from Glucosylated Precursors by Stable Isotope Dilution Assays Based on Liquid Chromatography−Tandem Mass Spectrometric DetectionJournal of Agricultural and Food Chemistry, 2008
- The Effect of Cinnamon on A1C Among Adolescents With Type 1 DiabetesDiabetes Care, 2007
- Insulin resistance and pancreatic cell failureJournal of Clinical Investigation, 2006
- Cinnamon Improves Glucose and Lipids of People With Type 2 DiabetesDiabetes Care, 2003